|
|
|
Sunday, March 18, 2012 — 1:30 p.m. — Convention Centre 205-207
|
- What is New in Dermatopathology? From Neoplastic to Inflammatory Conditions
|
|
Moderator:
|
Victor G. Prieto, UT - MD Anderson Cancer Center, Houston, TX
|
Click the button above to add this event to your Itinerary Planner...
| 1:30 |
What is New in Cutaneous Lymphomas? - Werner Kempf, Kempf und Pflatz Histologische Diagnostik, Zurich, Switzerland |
| 2:00 |
New Adjuvant Therapies: Cutaneous Effects (MDACC) - Jonathan L. Curry, UT - MD Anderson Cancer Center, Houston, TX |
| 2:30 |
What is New in Soft Tissue Tumors of the Skin? - Andrew Folpe, Mayo Clinic, Rochester, MN |
| 3:00 | Break |
| 3:30 |
What is New in Adnexal Tumors of the Skin? - Omar Sangueza, Wake Forest University School of Medicine, Winston-Salem, NC |
| 4:00 |
What is New in Melanocytic Tumors? - Pedram Gerami, Northwestern University, Chicago, IL |
| 4:30 | Discussion |
| The topic was chosen in a meeting of the Dermatopathology Section of Dermatopathology at MD Anderson Cancer Center to determine a unifying topic for an update course in dermatopathology. This course symposium will be primarily devoted to provided practical information to be applied to the day-to-day diagnosis of skin biopsies. The companion meeting will deal with new data related to the diagnosis and prognosis of cutaneous melanocytic lesions, cutaneous lymphomas, soft tissue tumors of the skin, and cutaneous adnexal tumors. Furthermore, from the exploding field of targeted therapy, the symposium will provide a discussion of the effects that these new medications induce in the skin. |
|
|
|
